|
![]() |
|||
|
||||
OverviewThis concise, comprehensive book provides the most recent updates on rosacea management strategy, pathophysiology, genetic and environmental contribution, comorbidities, and other various topics. It meets the market need for a book that examines topics that are not typically included in rosacea textbooks. Beginning with a discussion on the current clinical understanding of the disease, this book reviews the aforementioned topics in a thorough yet accessible fashion. Complete with tables detailing a variety of drugs in an unbiased manner as well as color photos of real patients, each chapter aims to relay useful, practical information to dermatologists at every stage in their career. A valuable contribution to the Updates in Clinical Dermatology Series, Rosacea aims to promote the rapid and efficient transfer of medical research into clinical practice for the benefit practitioners and patients alike. Full Product DetailsAuthor: John Havens Cary , Howard I. MaibachPublisher: Springer Nature Switzerland AG Imprint: Springer Nature Switzerland AG Edition: 1st ed. 2020 Weight: 0.396kg ISBN: 9783030520991ISBN 10: 3030520994 Pages: 152 Publication Date: 30 September 2021 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsErythematotelangiectatic rosacea: Redness, flushing, visible blood vessels.Papulopustular rosacea: Redness, swelling, and acne-like breakouts.Phymatous rosacea: Skin thickens and has a bumpy texture.Ocular rosacea: Eyes red and irritated, eyelids can be swollen, and person may have what looks like a sty. With time, people who have rosacea often see permanent redness in the center of their face. 1. Introduction to clinical rosacea (definition, incidence, history, physical exam, differential diagnosis, histology)2. Current Understanding of the pathophysiology3. Genetics of Rosacea 4. Role of Environment in Rosacea Part 1: Management: 5. Phenotype-based management: a new model for classifying and treating rosacea6. General treatment: evidence-based management7. Vasocontrictors: Oxymetazoline vs Brimonidine 8. Ocular Rosacea management9. Phymatous Rosacea management10. Papulopustular rosacea management11. Erythematotelangiectatic rosacea management12. Physical Modalities Part 2: Comorbidities: 13. GI comorbidities14. Neurological Comorbidities15. Cardiovascular Comorbidities:16. Malignancy comorbidities Part 3: Miscellaneous Topics 17. Psychosocial impact of Rosacea18. Demodex folliculorum: role in pathogenesis or association19. Rosacea in skin of color: masked, genetic differences, or protective effect of melanin responsible for decreased incidenceReviewsAuthor InformationJohn Havens Cary, MDLouisiana State UniversityNew Orleans, LAUSA Howard Maibach, MDUniversity of CaliforniaDermatology ClinicSan Francisco, CAUSA Tab Content 6Author Website:Countries AvailableAll regions |